APIRx Signs Multimillion Dollar Distributorship Contract

NEW YORK, NY–APIRx Pharmaceuticals B.V., today announced they have signed a multimillion dollar distributorship contract for its CheWell™ product with the American firm Prosperity Bhang.

ABOUT APIRX

APIRx Pharmaceuticals B.V. is a leading pharmaceutical company dedicated to manufacturing of natural cannabinoid API’s (Active Pharmaceutical Ingredients), which are extracted from cannabis plant material and purified to pharma grade. All manufacturing stages are performed under cGMP conditions. APIRx also uses its own API’s for the development of new Rx and OTC drugs, nutraceuticals, cosmeceuticals and other products.